# The Human Medicines Regulations 2012, Paragraph 23


For medicinal products included on the list referred to—
(a) in the case of a UKMA(NI) or a UKMA(UK)(Category 2), in Article 23 of Regulation (EC) No 726/2004, the symbol and statement “▼ This medicinal product is subject to additional monitoring”, or
(b) in the case of a UKMA(GB) or a UKMA(UK)(Category 1), in regulation 202A, the symbol and statement “▼ This medicinal product is subject to additional monitoring”.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/8/paragraph/23 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-8/paragraph-23
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.